How Long Before Wegovy Side Effects Go Away

Step 1, The first few days: what's happening and why it passes

Starting Wegovy at 0.25 mg is a deliberate clinical choice. That opening dose isn't designed to drive significant weight loss; it's there to let your digestive system adapt to the way semaglutide slows gastric emptying and signals fullness to the brain. The downside is that slowed emptying can cause nausea, bloating and discomfort, sometimes within hours of the first injection.

The good news is that the body acclimatises quickly. For the majority of people, nausea is at its worst in the first two or three days, then fades noticeably by the end of the first week, and our guide on how long before side effects of Wegovy typically appear explains the timing in more detail. Diarrhoea or constipation follows a similar arc. The NHS medicines page for semaglutide describes these early effects as common and usually mild, which matches what clinical trial data show: side effects in the STEP programme were most frequently reported as transient.

Practical things that help: eating smaller portions, avoiding fatty or spicy food in the days around your injection, and staying well hydrated. These aren't workarounds, they're genuinely effective at blunting the early response. If hunger itself seems to trigger nausea, semaglutide-related hunger nausea has its own explanation and its own set of strategies worth reading.

Step 2, Each dose increase: expect a short reset

Wegovy is titrated upward roughly every four weeks, moving from 0.25 mg through 0.5 mg, 1.0 mg, 1.7 mg and up to the 2.4 mg maintenance dose (with the newer 7.2 mg pen available for eligible patients). Each step up can bring a brief recurrence of the early symptoms, not because the treatment isn't working, but because the body needs a few days to readjust to the higher concentration.

This reset is usually shorter and milder than the very first experience. Most people report that by the second or third dose increase, they know what to expect and the discomfort feels manageable. Whether Wegovy side effects resolve permanently or recur at each step is a common question, and the honest answer is: a little of both, settling each time, and generally less pronounced at higher doses than at the start.

If a particular step-up feels disproportionately difficult, your prescriber can consider a slower titration schedule. That conversation is worth having rather than pushing through or stopping treatment unilaterally. Semaglutide's broader side-effect picture is covered in detail on the Wegovy side effects page.

Step 3, Maintenance dose: what lingers and what fades

Once the maintenance dose is established, most GI symptoms have settled considerably or disappeared. Reduced appetite persists, that's the intended effect. Some people notice fatigue or mild headache intermittently, but these rarely dominate daily life at this stage.

One side effect that concerns people and tends to emerge later rather than earlier is hair thinning. This is thought to be related to rapid caloric reduction and metabolic shift rather than the medicine itself, a phenomenon sometimes called telogen effluvium. It is usually temporary. The pattern of hair changes on Wegovy follows a broadly predictable course and tends to resolve as the body stabilises.

There is understandable frustration in the early weeks, nobody enjoys feeling queasy while also trying to build new habits. If that's where you are right now, that's a reasonable way to feel. Knowing that the worst is almost always front-loaded, and that most people who stay the course describe the side-effect burden as much lighter by month three, does seem to help people make an informed decision about continuing, and our dedicated page on how long until Wegovy side effects go away gives a realistic, stage-by-stage breakdown if you want more detail.

When to get medical help immediately

Most Wegovy side effects are uncomfortable rather than dangerous. A small number are neither. Know these signs and act on them.

Severe, persistent abdominal pain (particularly if it spreads toward the back, with or without vomiting) is the cardinal symptom of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting this risk for GLP-1 medicines: it is infrequent but serious, and it warrants same-day medical assessment. Do not wait to see if it settles.

Seek prompt help for any of the following: signs of a severe allergic reaction (swollen face, throat tightness, difficulty breathing), gallbladder-type pain (right-side upper abdominal pain after eating), signs of significant dehydration from prolonged vomiting or diarrhoea, or any change in mood or thoughts of self-harm. If you are unsure whether a symptom is urgent, NHS 111 is there for exactly that question.

Suspected side effects can be reported directly to the MHRA via the Yellow Card scheme. This matters, post-market safety reporting is how new patterns get identified and acted on. You can also raise concerns with our clinical team through the contact page, any day of the week.